Cryolife Company Profile (NYSE:CRY)

About Cryolife (NYSE:CRY)

Cryolife logoCryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:CRY
  • CUSIP: 22890310
  • Web:
  • Market Cap: $607 million
  • Outstanding Shares: 33,260,000
Average Prices:
  • 50 Day Moving Avg: $17.36
  • 200 Day Moving Avg: $17.92
  • 52 Week Range: $11.34 - $20.15
  • Trailing P/E Ratio: 59.25
  • Foreward P/E Ratio: 37.24
  • P/E Growth: 1.43
Sales & Book Value:
  • Annual Revenue: $182.42 million
  • Price / Sales: 3.33
  • Book Value: $6.42 per share
  • Price / Book: 2.84
  • EBIDTA: $25.17 million
  • Net Margins: 6.00%
  • Return on Equity: 8.37%
  • Return on Assets: 5.77%
  • Debt-to-Equity Ratio: 0.34%
  • Current Ratio: 5.74%
  • Quick Ratio: 4.71%
  • Average Volume: 182,206 shs.
  • Beta: 1.23
  • Short Ratio: 2.66

Frequently Asked Questions for Cryolife (NYSE:CRY)

What is Cryolife's stock symbol?

Cryolife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How were Cryolife's earnings last quarter?

Cryolife Inc (NYSE:CRY) posted its quarterly earnings data on Wednesday, April, 26th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.04 by $0.05. The business earned $45.10 million during the quarter, compared to the consensus estimate of $44.64 million. Cryolife had a net margin of 6.00% and a return on equity of 8.37%. Cryolife's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.10 EPS. View Cryolife's Earnings History.

When will Cryolife make its next earnings announcement?

Cryolife is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for Cryolife.

What guidance has Cryolife issued on next quarter's earnings?

Cryolife updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share (EPS) guidance of $0.40-0.43 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.41. The company issued revenue guidance of $188-192 million, compared to the consensus revenue estimate of $189.21 million.

Where is Cryolife's stock going? Where will Cryolife's stock price be in 2017?

5 equities research analysts have issued 1-year target prices for Cryolife's stock. Their forecasts range from $15.00 to $23.50. On average, they anticipate Cryolife's stock price to reach $19.60 in the next year. View Analyst Ratings for Cryolife.

Who are some of Cryolife's key competitors?

Who owns Cryolife stock?

Cryolife's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.70%), Morgan Stanley (5.47%), Vanguard Group Inc. (4.80%), Renaissance Technologies LLC (1.69%), Hancock Holding Co. (1.62%) and Elk Creek Partners LLC (1.53%). Company insiders that own Cryolife stock include C Elkins Ronald, David Ashley Lee, James Benson, James P Mackin, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for Cryolife.

Who sold Cryolife stock? Who is selling Cryolife stock?

Cryolife's stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Morgan Stanley, California Public Employees Retirement System, Credit Suisse AG, TIAA CREF Investment Management LLC, Driehaus Capital Management LLC, State Board of Administration of Florida Retirement System and Jane Street Group LLC. Company insiders that have sold Cryolife stock in the last year include C Elkins Ronald, Ronald D Mccall and Scott B Capps. View Insider Buying and Selling for Cryolife.

Who bought Cryolife stock? Who is buying Cryolife stock?

Cryolife's stock was bought by a variety of institutional investors in the last quarter, including Elk Creek Partners LLC, Dialectic Capital Management LP, Dimensional Fund Advisors LP, Royce & Associates LP, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Parametric Portfolio Associates LLC and Vanguard Group Inc.. View Insider Buying and Selling for Cryolife.

How do I buy Cryolife stock?

Shares of Cryolife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cryolife stock cost?

One share of Cryolife stock can currently be purchased for approximately $18.25.

Analyst Ratings

Consensus Ratings for Cryolife (NYSE:CRY) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.60 (7.40% upside)

Analysts' Ratings History for Cryolife (NYSE:CRY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/28/2017Northland SecuritiesReiterated RatingBuy$23.50LowView Rating Details
2/17/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$20.00N/AView Rating Details
1/23/2017Canaccord GenuityReiterated RatingBuy$23.50N/AView Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/AView Rating Details
6/15/2016Lake Street CapitalInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for Cryolife (NYSE:CRY)
Earnings by Quarter for Cryolife (NYSE:CRY)
Earnings History by Quarter for Cryolife (NYSE:CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 2017$0.04$0.09$44.64 million$45.10 millionViewN/AView Earnings Details
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/15/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cryolife (NYSE:CRY)
2017 EPS Consensus Estimate: $0.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.04$0.06$0.05
Q2 20172$0.07$0.11$0.09
Q3 20172$0.07$0.08$0.08
Q4 20172$0.09$0.11$0.10
(Data provided by Zacks Investment Research)


Current Dividend Information for Cryolife (NYSE:CRY)
Most Recent Dividend:12/18/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Cryolife (NYSE:CRY)

Dividend History by Quarter for Cryolife (NYSE:CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Cryolife (NYSE:CRY)
Insider Ownership Percentage: 6.08%
Institutional Ownership Percentage: 66.30%
Insider Trades by Quarter for Cryolife (NYSE:CRY)
Institutional Ownership by Quarter for Cryolife (NYSE:CRY)
Insider Trades by Quarter for Cryolife (NYSE:CRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/22/2017Scott B CappsVPSell11,083$16.40$181,761.20View SEC Filing  
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cryolife (NYSE:CRY)
Latest Headlines for Cryolife (NYSE:CRY)
DateHeadline logoETFs with exposure to CryoLife, Inc. : May 22, 2017 - May 22 at 4:20 PM logoC. R. Bard, Inc. (BCR) - May 14 at 4:36 PM logoETFs with exposure to CryoLife, Inc. : May 8, 2017 - May 8 at 9:23 PM logoCryolife (CRY) Receives Daily News Impact Rating of 0.03 - May 3 at 3:05 PM logoCryolife Inc (CRY) Given Average Recommendation of "Buy" by Brokerages - May 3 at 12:34 AM logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 - May 1 at 4:27 PM logoCryolife (CRY) Receives News Sentiment Score of 0.32 - April 29 at 9:35 PM logoCryoLife, Inc. – Value Analysis (NYSE:CRY) : April 28, 2017 - April 28 at 5:29 PM logoCryolife Inc (CRY) Earns "Buy" Rating from Northland Securities - April 28 at 2:58 PM logoCryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : April 27, 2017 - April 28 at 3:06 AM logoEdited Transcript of CRY earnings conference call or presentation 27-Apr-17 12:00pm GMT - April 28 at 3:06 AM logoCryoLife to Present at Deutsche Bank 42nd Annual Health Care Conference - April 27 at 10:05 PM logoCryoLife Q1 Profit Down - April 27 at 5:02 PM logoBRIEF-CryoLife reports Q1 non-GAAP earnings per share $0.09 - April 27 at 5:02 PM logoCryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at American Association for Thoracic Surgery Centennial Meeting - April 27 at 5:02 PM logoETFs with exposure to CryoLife, Inc. : April 27, 2017 - April 27 at 5:02 PM logoWhy CryoLife Inc. Jumped Higher - April 27 at 2:16 PM logoCryoLife Reports First Quarter 2017 Financial Results - April 27 at 2:07 AM logoCryoLife posts 1Q profit - April 27 at 2:07 AM logoCryolife Inc (CRY) Posts Earnings Results, Beats Estimates By $0.05 EPS - April 27 at 12:20 AM logoCryolife Inc (CRY) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS - April 26 at 11:24 PM logoCryolife Inc (CRY) Updates FY17 Earnings Guidance - April 26 at 10:02 PM logo Analysts Anticipate Cryolife Inc (CRY) Will Post Earnings of $0.04 Per Share - April 24 at 12:31 PM logoCryolife (CRY) Getting Somewhat Positive News Coverage, AlphaOne Reports - April 23 at 2:08 PM logoCryolife (CRY) Given News Sentiment Rating of 0.04 - April 20 at 9:00 PM logoGlobal $9.51 Billion Wound Closure Products Market 2016-2022 - Research and Markets - April 12 at 4:32 PM logoCryoLife Announces Release Date and Teleconference Call Details for 2017 First Quarter Financial Results - PR Newswire (press release) - April 12 at 8:13 AM logoCryoLife Announces Release Date and Teleconference Call Details for 2017 First Quarter Financial Results - April 11 at 1:02 PM logoGlobal Organ Preservation Market will reach USD 262.06 Million by 2022: Zion Market Research - April 7 at 9:13 AM logoETFs with exposure to CryoLife, Inc. : April 5, 2017 - April 7 at 9:13 AM logoCryolife Inc (CRY) Given Average Recommendation of "Buy" by Analysts - April 5 at 4:55 PM logoSurgical Sealants & Adhesives Market Size Worth $4.5 Billion By 2025: Grand View Research, Inc. - March 28 at 12:26 PM logoCRYOLIFE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr - March 23 at 4:59 PM logoSurgical Sealants And Adhesives Market Analysis By Type (Natural or Biological Adhesives & Sealants, … - March 22 at 9:38 PM logoMerit Medical (MMSI) to Refinance Debt via Share Offering - March 21 at 10:43 AM logoCRYOLIFE INC Files SEC form 8-K, Change in Directors or Principal Officers - March 16 at 5:52 PM logoCryolife Inc (CRY) Receives Consensus Rating of “Buy” from Brokerages - March 10 at 2:45 PM logoSurgical Sealants and Adhesives Market Worth 2.96 Billion USD by 2021 - March 3 at 4:33 PM logoForm 4 CRYOLIFE INC For: Feb 19 Filed by: Matthews William Robert - - February 23 at 4:28 PM logoCRYOLIFE INC Financials - February 22 at 4:43 PM logoCRYOLIFE INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; - February 21 at 4:55 PM logoCryolife 4Q Revenues Missed Street Estimates (CRY) - February 17 at 5:35 PM logoCryoLife upgraded by Ladenburg Thalmann - February 17 at 5:35 PM logoCryolife 4Q Revenues Missed Street Estimates - February 17 at 5:35 PM logoEdited Transcript of CRY earnings conference call or presentation 16-Feb-17 1:00pm GMT - February 16 at 9:43 PM logoEdited Transcript of CRY earnings conference call or presentation 16-Feb-17 1:00pm GMT - February 16 at 9:43 PM logoBRIEF-CryoLife reports Q4 adj. earnings per share $0.12 - February 16 at 12:29 PM logoQ4 2016 CryoLife Inc Earnings Release - After Market Close - February 16 at 12:29 PM logoCryoLife Reports Fourth Quarter and Full Year 2016 Financial Results - February 16 at 12:29 PM logo5:28 pm CryoLife beats by $0.01, misses on revs; guides FY17 EPS in-line, revs in-line - February 16 at 12:29 PM



Cryolife (CRY) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff